ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged

A. Kucheryavaya,1 R. Bray,2 A. Miller,1 D. Tyan.3

1UNOS, Richmond
2Emory University Hospital, Atlanta
3Stanford University, Palo Alto.

Meeting: 2015 American Transplant Congress

Abstract number: D64

Keywords: HLA antibodies, Kidney transplantation, Public policy, Sensitization

Session Information

Date: Tuesday, May 5, 2015

Session Name: Poster Session D: Immunology, Biomarkers and Immunosuppression

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Related Abstracts
  • Low Expanded Criteria Donor Listing Rates by Organ Procurement Organization Is Associated With Increased Differential in Waiting Time for Candidates Willing to Accept Marginal Organs in the US
  • Geographic Variation in Listing Practices Represents Competetive Behaviors and Access to Care Rather Than Differences in Demand for Liver Transplantation

Background: CPRA is the % of deceased donors expected to have one or more UAs with a given candidate. Prior to 12/5/13, candidates with UA-C were excluded from offers but their CPRA did not reflect those UAs. On 12/5/13, the CPRA formula was modified to include HLA-C.

Data and Methods: This study was performed for the OPTN Histocompatibility Committee using OPTN data. Patterns of reporting UA-C for kidney registrations (KRegs) were examined before and after the change to determine if the addition of C to CPRA calculation resulted in increased reporting of UA-C. In addition, the impact of the change was evaluated by comparing CPRA value without UA-C to the new CPRA value (including UA-C). HLA and ethnic frequencies were updated prior to the assessment. The study population included all KRegs with UA-C on the Waitlist at the time of the change (N=11315).

Results: % of KRegs with UA-Cs reported on the Waitlist had increased between 2006 and 2011. However, subsequent to the change, reporting remained stable (0.9% on 9/30/06, 10.8% on 9/30/13, 10.3% on 9/30/14). In contrast, the addition of C resulted in increased CPRA for 6435 (56.9%) KRegs with UA-C. The % increase in CPRA ranged from 1% (22%), 2-4% (24%), 5-9% (17%), to ≥10% points (37%) (Fig 1). CPRA increased from <80% to ≥80% for 573 KRegs, making them eligible for 4 additional allocation points. 6702 of the KRegs with UA-C would move into a higher CPRA group based on a sliding CPRA scale used for the New KI allocation (KAS) starting 12/4/14. CPRA values remained the same for 4880 (43.1%) KRegs with UA-C but of these, 81.3% had 100% CPRA value without UA-C.

Conclusions: Following the addition of C into the CPRA calculation, reporting of UA-C on the waiting list remained stable suggesting that centers did not change their practices. However, the CPRA values for some candidates were substantially affected in that 21.2% of KRegs with UA-Cs increased their CPRA by ≥10% points and 5.1% moved into the ≥80% category ensuring appropriate and equitable allocation priority.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kucheryavaya A, Bray R, Miller A, Tyan D. CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/cpra-values-are-substantially-increased-for-some-candidates-subsequent-to-inclusion-of-unacceptable-c-locus-ua-c-antigens-while-listing-practices-remain-unchanged/. Accessed January 18, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
  • Hyperkalemia in the Early Post Renal Transplant Period

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.